Business
Why the Starpharma (ASX:SPL) share price hit a record high today
The Starpharma Holdings Limited (ASX: SPL) share price has been a very positive performer on Tuesday.
At one stage today, the dendrimer product developer’s shares jumped 7.5% to hit a record high of $2.10.
The Starpharma share price has since given back some of these gains but is still up 4% to $2.03 at the time of writing.
Why is the Starpharma share price racing higher?
Investors have been buying Starpharma’s shares after it provided an update on its AZD0466 product.
AZD0466 is a highly optimised nanomedicine formulation of AstraZeneca’s novel dual Bcl2/xL inhibitor which utilises Starpharma’s DEP technology. It utilises DEP to improve the formulation characteristics and therapeutic index of the anti-cancer agent and is…
-
Business17 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Noosa News15 hours agoPill checking to resume in Queensland months after government axed funding
-
Business19 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Noosa News23 hours agoThe Full Trailer for Yorgos Lanthimos’ Emma Stone-Led CEO-Kidnapping Dark Comedy ‘Bugonia’ Is Here